HCQ in COVID-19 under Trial: With RCTs in Witness Box
Guest article by Dr Dhananjay Bakhle, Executive Vice President – Medical Research, Lupin. One of the most important aspects of a clinical trial publication is
Guest article by Dr Dhananjay Bakhle, Executive Vice President – Medical Research, Lupin. One of the most important aspects of a clinical trial publication is
Some of you may remember Bernie Laplante, played by Dustin Hoffman in the 1992 movie Accidental Hero? He saved many lives, but no-one recognized him
Just four months ago, on March 20, the first study from IHU-Marseille showing the effectiveness of hydroxychloroquine associated with azithromycin in reducing the viral load
Since mid-March, early treatments were known to have great potential as a cure for COVID-19. Dr Zelenko was already treating his patients in NY State
With the peak of the COVID-19 crisis behind us, for many of us, we talk to more people, and obviously, a main topic remains the
General practitioners and specialized doctors operating outside hospital settings played a key role in the fight against COVID-19 in France. There are over 100,000 of
Hydroxychloroquine-based treatments for COVID-19 are recommended by experts such as Professor Didier Raoult for an early therapeutic intervention, typically within 5 days of the first
This article reviews the clinical trial protocol announced this May 14 by the National Institutes of Health in the US, to study the effectiveness of
There was much anticipation regarding the New York study on hydroxychloroquine, with results announced on May 7, even if it was among those studies that
Yes, you read it well. Chris Cuomo, the famous anchor of one of the news outlets the most active in denigrating hydroxychloroquine, has been revealed
As early as 1964, the World Medical Association developed the Helsinki Declaration as a statement of ethical principles applicable to medical research involving humans. This
Three medical doctors, James M. Todaro, MD (Columbia MD), Moshe E. Praver, MD (Columbia MD) and Vladimir Zelenko, MD, along with investor Joey Krug, issued